Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable tech reveals hidden health patterns in older breast cancer patients

NCT ID NCT05634395

Knowledge-focused Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study gives women over 70 being treated for breast cancer a wrist-worn activity tracker to wear for a year. Researchers will analyze daily step counts and sleep duration to describe different physical activity and sleep profiles. They will also see how these profiles relate to quality of life, fatigue, and other health factors. The goal is to better understand the real-world activity and sleep patterns of older breast cancer patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
activity tracker (Withings Steel)
What this could lead to
If successful, this could help identify patterns of physical activity and sleep that are linked to better quality of life in older breast cancer survivors, potentially guiding future supportive care.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly improve outcomes. The results may not apply to all older patients, and the tracker data may not capture all meaningful aspects of activity or sleep.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Feb 2023

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women over 70 years of age, * With histologically confirmed invasive breast cancer, * Regardless of histological subtype (hormone receptor positive (HR+), negative (HR-), with or without HER2 overexpression, or triple negative) * Treated with local (surgery, radiotherapy) or systemic (hormone therapy, monotherapy, anti HER2, chemotherapy: patient is eligible for inclusion up to one month after initial diagnosis or recurrence (local or distant) of breast cancer, * PS ≤ 2, * Willing and available to invest in the project for the duration of the study, * Using a personal smartphone or personal tablet compatible with the "Withings Health Mate" app (iOS 10/android 5.0 and later) and with an internet connection, * Affiliated with a social security plan, * Having dated and signed an informed consent, * Able to read, write and understand French. Exclusion Criteria: * Presence of disabling metastases, * Moderate to severe cognitive impairment, * Persons deprived of liberty or under guardianship, * Inability to undergo the medical follow-up of the trial for geographical, social or psychological reasons,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

Contacts and locations

Locations

  • Centre Léon Bérard

    Lyon, 69008, France

  • Institut Curie

    Paris, 75005, France

  • Institut Curie

    Saint-Cloud, 92210, France

  • Institut GODINOT

    Reims, 51100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.